Insider · CIK 0001801050

Welgus Howard G.

Reports to the SEC for 1 company · WESTLAKE VILLAGE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001801050

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+822 sh	$6.52	+$5,361.331	36,663
2026-10-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,018 sh	$7.51	+$7,645.18	37,681
2026-10-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,254 sh	$8.63	+$19.5K	39,935
2026-10-15	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−4,728 sh	$26.93	−$127K	35,207
2026-10-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−822 sh	—	—	5,752
2026-10-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,018 sh	—	—	7,126
2026-10-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,254 sh	—	—	15,778
2026-09-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+822 sh	$6.52	+$5,361.331	37,297
2026-09-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,019 sh	$7.51	+$7,652.69	38,316
2026-09-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,255 sh	$8.63	+$19.5K	40,571
2026-09-15	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−4,730 sh	$24.18	−$114K	35,841
2026-09-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−822 sh	—	—	6,574
2026-09-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,019 sh	—	—	8,144
2026-09-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,255 sh	—	—	18,032
2026-08-17	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+822 sh	$6.52	+$5,361.331	37,931
2026-08-17	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,019 sh	$7.51	+$7,652.69	38,950
2026-08-17	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,255 sh	$8.63	+$19.5K	41,205
2026-08-17	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−4,730 sh	$26.18	−$124K	36,475
2026-08-17	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−822 sh	—	—	7,396
2026-08-17	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,019 sh	—	—	9,163
2026-08-17	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,255 sh	—	—	20,287
2026-07-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+822 sh	$6.52	+$5,361.331	38,565
2026-07-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,019 sh	$7.51	+$7,652.69	39,584
2026-07-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,255 sh	$8.63	+$19.5K	41,839
2026-07-15	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−4,730 sh	$26.91	−$127K	37,109
2026-07-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−822 sh	—	—	8,218
2026-07-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,019 sh	—	—	10,182
2026-07-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,255 sh	—	—	22,542
2026-06-17	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−635 sh	$25.67	−$16.3K	37,743
2026-06-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+822 sh	$6.52	+$5,361.331	39,200
2026-06-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,019 sh	$7.51	+$7,652.69	40,219
2026-06-15	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,255 sh	$8.63	+$19.5K	42,474
2026-06-15	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−4,096 sh	$24.41	−$100K	38,378
2026-06-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−822 sh	—	—	9,040
2026-06-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,019 sh	—	—	11,201
2026-06-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,255 sh	—	—	24,797
2026-06-05	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+5,778 sh	—	—	38,378
2026-06-05	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,667
2026-05-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−7,144 sh	$22.99	−$164K	32,600
2026-04-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$23.88	−$239K	39,744
2026-03-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$25.65	−$257K	49,744
2026-02-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$25.05	−$250K	59,744
2026-01-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$28.96	−$290K	69,744
2025-12-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$30.21	−$302K	79,744
2025-11-03	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$25.27	−$253K	89,744
2025-10-01	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,538 sh	$1.68	+$16K	109,744
2025-10-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−9,538 sh	$18.92	−$180K	100,206
2025-10-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−462 sh	$18.92	−$8,742.287	99,744
2025-10-01	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,538 sh	—	—	0
2025-09-02	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	—	—	110,206

Recent filings

Accepted (ET)
Oct 194
Welgus Howard G.0001628280-26-066331
SEC(opens sec.gov)
Sep 174
Welgus Howard G.0001628280-26-062490
SEC(opens sec.gov)
Aug 194
Welgus Howard G.0001628280-26-058008
SEC(opens sec.gov)

Companies

Arcutis Biotherapeutics, Inc.DirectorARQT

Address

C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300

WESTLAKE VILLAGE, CA, 91361